YAP-TEAD Program (Beactica Therapeutics)

N/A

Report date: 2025/01/26 16:15:14
NME

Base Information

Drug NameYAP-TEAD Program (Beactica Therapeutics)
Drug Alias NameHippo Signaling Pathway Modulators (Beactica Therapeutics)TEAD inhibitor (Beactica Therapeutics)YAP/TEAD interaction inhibitor (Beactica Therapeutics)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTranscriptional enhancer factor inhibitorsTranscriptional coactivator YAP1 inhibitors
TargetsTranscriptional coactivator YAP1Transcriptional enhancer factor
Therapy Area/IndicationsSolid tumoursMesotheliomaNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySweden
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBeactica Therapeutics AB
China Registration ClassN/A

Develop Information

Active CompaniesBeactica Therapeutics AB
Inactive CompaniesN/A
Active IndicationsSolid tumoursMesothelioma
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A